
Silverberry Genomix is a leading digital health platform that utilizes DNA testing, AI, and machine learning to provide personalized assessments and recommendations to optimize health and wellness plans. The company differentiates itself through its comprehensive DNA health and wellness reports, which are based on extensive scientific research and are designed to inform healthcare decisions. With a focus on precision health, Silverberry leverages generative AI to enhance administrative efficiency and improve patient engagement. The platform is positioned to modernize healthcare practices, save time and money for providers, and optimize client health outcomes, making it a compelling option in the growing digital health market.

Silverberry Genomix is a leading digital health platform that utilizes DNA testing, AI, and machine learning to provide personalized assessments and recommendations to optimize health and wellness plans. The company differentiates itself through its comprehensive DNA health and wellness reports, which are based on extensive scientific research and are designed to inform healthcare decisions. With a focus on precision health, Silverberry leverages generative AI to enhance administrative efficiency and improve patient engagement. The platform is positioned to modernize healthcare practices, save time and money for providers, and optimize client health outcomes, making it a compelling option in the growing digital health market.
What they do: DNA lifestyle company using genomics + AI to generate personalized wellness reports.
Headquarters: San Francisco, United States.
Founded: March 2017.
Products: Digital, downloadable DNA-based report packages (nutrition, exercise/fitness, skincare, allergies, personality, longevity/weight-loss).
Investor signal: MATTER Health listed as an investor (Sep 2021); amount undisclosed.
Consumer genomics and personalized wellness recommendations.
2017
DNA lifestyle / digital health / consumer genomics
“MATTER Health listed as an investor (Sep 2021); funding amount not disclosed.”